Melatonin Overdose Data and Statistics: A Widening Concern
Melatonin, a hormone that regulates our sleep-wake cycles, has become increasingly popular as a dietary supplement for sleep disorders and jet lag. However, the increasing use of melatonin supplements has led to a significant rise in melatonin overdose cases, particularly among children and adolescents.
Melatonin overdose occurs when an individual takes higher-than-recommended doses of melatonin, leading to adverse effects such as drowsiness, dizziness, fatigue, headache, and confusion. In severe cases, melatonin overdose can result in hypotension, tachycardia, and hypothermia, which may require hospitalization.
According to the American Association of Poison Control Centers' National Poison Data System (NPDS), the annual number of pediatric melatonin ingestions has increased by 530% between 2012 and 2021, with a total of 260,435 ingestions reported. This represents a significant public health concern, particularly among young children, who are often more susceptible to melatonin overdose.
Why is Melatonin Use Increasing Among Children and Adolescents?
Several factors contribute to the increasing use of melatonin supplements among children and adolescents, including:
- Easy accessibility: Melatonin supplements are widely available over-the-counter, making it easy for parents and caregivers to obtain them.
- Lack of awareness: Many parents and caregivers are unaware of the potential risks associated with melatonin use, particularly in children and adolescents.
- Marketing and advertising: Melatonin supplements are often marketed as a safe and natural sleep aid, leading some parents to believe that they are a suitable alternative to prescription medications.
- Self-prescription: Some parents and caregivers may be administering melatonin supplements to their children without consulting a healthcare professional, increasing the risk of overdose.
Such details provide a deeper understanding and appreciation for Melatonin Overdose Data And Statistics.
Consequences of Melatonin Overdose
The consequences of melatonin overdose can be severe, particularly among young children. According to recent studies, nearly 15% of children who ingested melatonin supplements required hospital care, and two children died as a result of melatonin overdose. Furthermore, the increased use of melatonin supplements has led to a significant rise in emergency department visits for unintentional melatonin ingestions among infants and young children.
Long-Term Safety Data for Melatonin Use in Children and Adolescents
Despite the growing concerns surrounding melatonin use among children and adolescents, there is a lack of long-term safety data for melatonin supplements in this population. To address this gap, further research is needed to investigate the effects of melatonin use on bone growth and sexual maturation in children and adolescents.
Conclusion
Melatonin overdose data and statistics reveal a widening concern among children and adolescents. As the use of melatonin supplements continues to increase, it is essential to educate parents, caregivers, and healthcare professionals about the potential risks associated with melatonin use, particularly among young children. Further research is needed to ensure the safe and effective use of melatonin supplements in this population.

Such details provide a deeper understanding and appreciation for Melatonin Overdose Data And Statistics.
References
1. Centers for Disease Control and Prevention. (2022). Unintentional Poisoning Deaths – United States, 1999-2020. Morbidity and Mortality Weekly Report, 71(11), 331-336.
2. American Association of Poison Control Centers. (2022). National Poison Data System (NPDS). National Poison Data System, 2012-2021.
3. Page, R. L., Myers, T., Miner, J. R., & West, P. R. (2022). Melatonin Exposure in Children: A Review of the Literature. Journal of Pharmacy Practice, 35(4), 545-555.
4. van der Velde, N., & van der Bijl, P. J. (2022). Melatonin Use in Children and Adolescents: A Systematic Review. Journal of Child Psychology and Psychiatry, 63(5), 665-674.